Posted by Michael Wonder on 11 Feb 2016

Panel recommends FDA approval of Remicade knockoff

Wall Street Journal

10 February 2016 - Vote on copy of J&J arthritis drug comes as makers of biotech brands are poised for fierce patent battles.

For more details, go to: http://www.wsj.com/articles/panel-recommends-fda-approval-of-remicade-knockoff-1455057993?mod=asia&mod=djemITPA_t

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US , Biosimilar